Gordon Stephen 4
4 · TransMedics Group, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Gordon Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-06-03−2,060→ 15,417 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (2,060 underlying) - Exercise/Conversion
Common Stock
2024-06-03$38.46/sh+2,060$79,228→ 23,359 total - Sale
Common Stock
2024-06-03$135.93/sh−2,060$280,016→ 21,299 total
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
- [F2]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.